N25.1
Nephrogenic diabetes insipidus
Clinical Classification Guidelines
Excludes Type 1
- diabetes insipidus NOS (E23.2)
Medical Intelligence & Overview
Nephrogenic diabetes insipidus (NDI) is a rare condition where the kidneys are unable to respond properly to vasopressin, a hormone that regulates water balance in the body. As a result, affected individuals produce large amounts of dilute urine, leading to dehydration and imbalances in electrolyte levels. This condition is classified under ICD-10 code N25.1 and differs from other types of diabetes insipidus because the problem originates within the kidneys themselves, rather than from a deficiency of the hormone vasopressin.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting kidney function Certain medications, such as lithium or demeclocycline Electrolyte imbalances, like hypercalcemia or hypokalemia Chronic kidney disease or damage Acquired from conditions leading to kidney injury
Key Symptoms: Excessive thirst and increased fluid intake Passing very large amounts of urine, often clear and dilute Dehydration symptoms, including dry mouth and skin Electrolyte imbalances causing muscle weakness or cramps Fatigue and general discomfort Potential weight loss due to fluid loss
Diagnostic & Treatment
Diagnosis Path: Diagnosis of nephrogenic diabetes insipidus involves a series of tests to evaluate kidney response and hormone levels. Key diagnostic steps include: - Water deprivation test: Monitors urine concentration response to fluid restriction. - Vasopressin (or desmopressin) challenge test: Differentiates between different types of diabetes insipidus. - Blood tests: Check for electrolyte imbalances and renal function. - Urinalysis: Measures urine volume and concentration. A definitive diagnosis often involves ruling out other causes of similar symptoms, such as central diabetes insipidus.
Treatment Protocols: Management of nephrogenic diabetes insipidus focuses on controlling symptoms and preventing dehydration. Approaches include: - Adequate hydration: Ensuring sufficient fluid intake to replace losses. - Dietary modifications: Reducing intake of salt and protein to decrease urine output. - Use of medications like thiazide diuretics and non-steroidal anti-inflammatory drugs (NSAIDs), which may help reduce urine volume. - Addressing underlying causes: Discontinuing offending medications or treating kidney disease. - Regular monitoring: Tracking electrolyte levels and kidney function to prevent complications. In some cases, supportive care and ongoing medical management are essential to maintaining quality of life.
Clinical Advice & FAQs
Billing Guidance
Is N25.1 a billable ICD-10 code?
Yes, N25.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N25.1?
Clinical documentation must specify the nature of Nephrogenic diabetes insipidus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
